193 related articles for article (PubMed ID: 26939245)
1. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
[TBL] [Abstract][Full Text] [Related]
2. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
[TBL] [Abstract][Full Text] [Related]
3. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
4. The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
Colatrella B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():7-11. PubMed ID: 18718147
[TBL] [Abstract][Full Text] [Related]
5. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
[TBL] [Abstract][Full Text] [Related]
6. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
[TBL] [Abstract][Full Text] [Related]
8. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
9. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
Ogbuagu KF; Eneanya CI
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
York KJ; Kabole I; Mrisho M; Berry DM; Schmidt E
J Nurs Scholarsh; 2015 Jan; 47(1):96-104. PubMed ID: 25565278
[TBL] [Abstract][Full Text] [Related]
11. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
12. Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
Ogoussan KT; Hopkins A
Acta Trop; 2011 Sep; 120 Suppl 1():S173-6. PubMed ID: 20974105
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria.
Oyibo WA; Fagbenro-Beyiku AF
East Afr Med J; 1998 Apr; 75(4):237-42. PubMed ID: 9745842
[TBL] [Abstract][Full Text] [Related]
14. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
15. Maintaining compliance to ivermectin in communities in two West African countries.
Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
[TBL] [Abstract][Full Text] [Related]
16. Assessing Hypoendemic Onchocerciasis in
Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
[TBL] [Abstract][Full Text] [Related]
17. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Thylefors B; Alleman MM; Twum-Danso NA
Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
[TBL] [Abstract][Full Text] [Related]
18. Household coverage of ivermectin distribution in birnin kudu local government area of Jigawa State, Nigeria.
Raji LA; Babalola OE; Musa D; Hassan A; Raji I; Umar MM; Ogungbenjo JA; Alhassan MB
Ann Afr Med; 2023; 22(3):252-258. PubMed ID: 37417010
[TBL] [Abstract][Full Text] [Related]
19. Problems and perspectives of managing an onchocerciasis control programme: a case study from Plateau state, Nigeria.
Miri ES
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S121-8. PubMed ID: 9861277
[TBL] [Abstract][Full Text] [Related]
20. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
Adewale B; Oyerinde JP; Mafe MA
West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]